Medicare Enrolled
Dr. Nimmy Treeza, APN
Nurse Practitioner - Adult Health · Eatontown, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Treeza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Treeza?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Treeza
Dr. Nimmy Treeza is a nurse practitioner - adult health in Eatontown, NJ, with 9 years of NPI registration. Based on federal Medicare data, Dr. Treeza performed 6,428 Medicare services across 546 unique beneficiaries.
Between the years covered by Open Payments, Dr. Treeza received a total of $4,850 from 61 pharmaceutical and/or device companies across 270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - adult health. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Treeza is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years in practice
▲ Top 1% volume in NJ
$4,850 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,428
Medicare services
Top 1% in NJ for nurse practitioner - adult health
546
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~714 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
4,700 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
1,000 | $6 | $50 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
148 | $7 | $33 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
135 | $8 | $16 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
87 | $21 | $140 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
85 | $91 | $227 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
51 | $1 | $16 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
49 | $10 | $84 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
36 | $46 | $285 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
27 | $98 | $620 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
25 | $1 | $6 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
23 | $54 | $201 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
20 | $59 | $175 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
16 | $95 | $269 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
15 | $1 | $14 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 11 | $57 | $188 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.3% high complexity
90.4% medium
7.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,850
Total received (2021-2024)
Avg $1,213/year across 4 years
Top 6% in NJ for nurse practitioner - adult health
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
270
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,381 (90.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$470 (9.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,171
2023
$1,270
2022
$1,437
2021
$972
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Daiichi Sankyo Inc.
$233
ABBVIE INC.
$109
Merck Sharp & Dohme LLC
$93
Incyte Corporation
$72
Takeda Pharmaceuticals U.S.A., Inc.
$62
Pharmacosmos Therapeutics Inc.
$58
GlaxoSmithKline, LLC.
$51
Bayer Healthcare Pharmaceuticals Inc.
$48
Myriad Genetic Laboratories, Inc.
$43
Tempus AI, Inc
$38
Novartis Pharmaceuticals Corporation
$36
Eisai Inc.
$35
Gilead Sciences, Inc.
$33
Genmab U.S., Inc.
$25
Rigel Pharmaceuticals, Inc.
$20
Genentech USA, Inc.
$20
SOBI, INC
$19
Kyowa Kirin, Inc.
$18
Karyopharm Therapeutics Inc.
$18
Regeneron Healthcare Solutions, Inc.
$17
PFIZER INC.
$17
PUMA BIOTECHNOLOGY, INC.
$17
Acrotech Biopharma Inc.
$16
JAZZ PHARMACEUTICALS INC.
$16
Octapharma USA, Inc.
$15
Deciphera Pharmaceuticals Inc.
$15
E.R. Squibb & Sons, L.L.C.
$14
Lilly USA, LLC
$14
Top 3 companies account for 37.1% of 2024 payments
All-time payments by company (2021-2024) ›
Seagen Inc.
$535
Daiichi Sankyo Inc.
$524
Eisai Inc.
$257
Incyte Corporation
$221
Merck Sharp & Dohme LLC
$212
Pharmacosmos Therapeutics Inc.
$202
ABBVIE INC.
$193
Amgen Inc.
$172
Celgene Corporation
$145
Janssen Biotech, Inc.
$121
Bayer Healthcare Pharmaceuticals Inc.
$114
GlaxoSmithKline, LLC.
$113
Novartis Pharmaceuticals Corporation
$113
Lilly USA, LLC
$100
Merck Sharp & Dohme Corporation
$84
Bayer HealthCare Pharmaceuticals Inc.
$84
Takeda Pharmaceuticals U.S.A., Inc.
$76
Astellas Pharma US Inc
$72
EISAI INC.
$71
E.R. Squibb & Sons, L.L.C.
$69
PUMA BIOTECHNOLOGY, INC.
$59
Karyopharm Therapeutics Inc.
$54
Kite Pharma, Inc.
$53
CTI BioPharma Corp.
$50
Gilead Sciences, Inc.
$50
Coherus Biosciences Inc.
$50
Kyowa Kirin, Inc.
$48
AVEO Pharmaceuticals, Inc.
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$47
Puma Biotechnology, Inc.
$46
Taiho Oncology, Inc.
$45
Deciphera Pharmaceuticals Inc.
$44
AstraZeneca Pharmaceuticals LP
$44
Myriad Genetic Laboratories, Inc.
$43
EMD Serono, Inc.
$43
Genmab U.S., Inc.
$41
JAZZ PHARMACEUTICALS INC.
$41
Acrotech Biopharma LLC
$40
Tempus AI, Inc
$38
Regeneron Healthcare Solutions, Inc.
$35
G1 Therapeutics, Inc.
$33
Epizyme, Inc.,
$31
PFIZER INC.
$31
Pharmacyclics LLC, An AbbVie Company
$30
Myovant Sciences Inc.
$30
AbbVie Inc.
$27
Acceleron Pharma, Inc.
$24
Spectrum Pharmaceuticals Inc.
$23
Sobi, Inc
$21
Rigel Pharmaceuticals, Inc.
$20
Genentech USA, Inc.
$20
GENZYME CORPORATION
$20
Dendreon Pharmaceuticals LLC
$19
SOBI, INC
$19
TAIHO ONCOLOGY, INC.
$18
RECORDATI_RARE_DISEASES_INC.
$17
Acrotech Biopharma Inc.
$16
Octapharma USA, Inc.
$15
MorphoSys, US Inc.
$15
Agios Pharmaceuticals, Inc.
$14
Mylan Institutional Inc.
$14
Top 3 companies account for 27.1% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · ALUNBRIG · AREXVY · Alecensa · BELEODAQ · CALQUENCE · COSELA · CYRAMZA · DARZALEX · DOPTELET · ENHERTU · EPKINLY · EXKIVITY · Enhertu · Epkinly · FASENRA · FOTIVDA · FRUZAQLA · GILOTRIF · IBRANCE · IMBRUVICA · INJECTAFER · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · Lenvima · MONJUVI · MONOFERRIC · MYRISK · NERLYNX · NINLARO · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · PADCEV · PLUVICTO · POTELIGEO · PROVENGE · PYRUKYND · Padcev · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · ROLVEDON · Reblozyl · Revlimid · Rezlidhia · SCEMBLIX · SHINGRIX · SYLVANT · Stivarga · TAZVERIK · TUKYSA · Tivdak · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · VONJO · Vonjo · XPOVIO · XT CDX · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for nurse practitioner - adult health in NJ.
Geographic Context
Adult-health nurse practitioners within 10 mi
622
Per 100K population
96.6
County median income
$122,727
Nearest hospital
RIVERVIEW MEDICAL CENTER
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Treeza is a mixed practice specialist, with above-average Medicare volume (top 1% in NJ), with low-engagement industry engagement in the top 6% of NJ peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Treeza experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Treeza performed 4,700 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Treeza receive payments from pharmaceutical companies?
Yes. Dr. Treeza received a total of $4,850 from 61 companies across 270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Treeza's costs compare to other adult-health nurse practitioners in Eatontown?
Dr. Treeza's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Treeza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Adult-Health Nurse Practitioners in Eatontown
Browse adult-health nurse practitioners in Eatontown ranked by procedure volume and transparency data.
Highest volume
Top Adult-Health Nurse Practitioners in NJ
Adult-health nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Adult-Health Nurse Practitioners in NJ
Which NJ adult-health nurse practitioners receive the most from drug and device companies.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
Eisai Inc. Payments to Doctors
See all physicians who received payments from Eisai Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology